Lixte Biotechnology Holdings Inc.(LIXT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LIXT Lixte Biotechnology Holdings Inc.

交易中 02-25 13:15:24 EST

3.18

+0.21

+6.90%

最高3.29	最低2.99	成交量2.57万
今开2.99	昨收2.97	日振幅10.10%
总市值2,763万	流通市值2,537万	总股本870.31万
成交额8.03万	换手率0.32%	流通股本799.21万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LIXT","market":"US","secType":"STK","nameCN":"Lixte Biotechnology Holdings Inc.","latestPrice":3.175,"timestamp":1772043298323,"preClose":2.97,"halted":0,"volume":25729,"delay":0,"changeRate":0.06902356902356889,"floatShares":7992100,"shares":8703100,"eps":-1.211027,"marketStatus":"交易中","change":0.205,"latestTime":"02-25 13:15:24 EST","open":2.99,"high":3.29,"low":2.99,"amount":80278.8127636,"amplitude":0.10101,"askPrice":3.2,"askSize":1500,"bidPrice":3.11,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-1.211027,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"adr":0,"listingDate":1606280400000,"exchange":"NASDAQ","adjPreClose":2.97,"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"17:12 EST","volume":3,"amount":8.85,"timestamp":1771971126799,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.544646},"requestUrl":"/m/hq/s/LIXT","defaultTab":"news","newsList":[{"id":"2610098961","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大跌8.92%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610098961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610098961?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:55","pubTimestamp":1770821758,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时55分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价快速下挫8.92%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Quince Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Pmgc Holdings Inc.涨幅较大，Pmgc Holdings Inc.、Quince Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1955.55%、318.32%、179.98%，振幅较大的相关个股有Quince Therapeutics, Inc.、Tuhura Biosciences, Inc.、Biorestorative Therapies, Inc.，振幅分别为27.25%、23.08%、21.76%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211225558a4988e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211225558a4988e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"gpt_icon":0},{"id":"2604941923","title":"Lixte Biotechnology Holdings, Inc.盘中异动 早盘股价大涨5.58%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604941923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604941923?lang=zh_cn&edition=full","pubTime":"2026-01-17 00:27","pubTimestamp":1768580853,"startTime":"0","endTime":"0","summary":"北京时间2026年01月17日00时27分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速拉升5.58%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117002733a723af1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117002733a723af1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"gpt_icon":0},{"id":"2602134595","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大跌5.46%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602134595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602134595?lang=zh_cn&edition=full","pubTime":"2026-01-09 03:37","pubTimestamp":1767901068,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日03时37分，Lixte Biotechnology Holdings, Inc.股票出现异动，股价大幅下挫5.46%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体跌幅为2.05%。其相关个股中，Enliven Therapeutics, Inc.、Century Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为523.88%、126.79%、81.10%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Enliven Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为146.48%、59.43%、52.53%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109033748a4ad21a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109033748a4ad21a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXT"],"gpt_icon":0},{"id":"1114626254","title":"Lixte Biotechnology Holdings Inc. 拓展与德克萨斯大学MD安德森癌症中心及葛兰素史克对Lb-100的合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1114626254","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114626254?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:13","pubTimestamp":1766495589,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 拓展与德克萨斯大学MD安德森癌症中心及葛兰素史克在Lb-100项目上的合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1202635105.USD","LU1481599808.USD","LU0971552830.HKD","LU0306806265.USD","LU0985481810.HKD","BK5011","LU1670756490.USD","LU0289739699.SGD","BK4139","LU0109981661.USD","IE00BQJZX424.USD","LU0225284248.USD","IE00B3T34201.USD","LU1228905037.USD","LU0203347892.USD","LU0161305163.EUR","LU1015430645.USD","LU1481600234.SGD","LU1309081286.SGD","LU1035777561.USD","IE0034235071.USD","LU1064927863.SGD","LU0203345920.USD","GSK.UK","LU1046248800.SGD","LU0225771236.USD","LU1302929846.USD","LU1400636491.USD","LU1487256676.USD","LU1098665638.USD","LU1228905540.USD","LU0321505439.SGD","IE00BWDBJ516.SGD","LU0575583348.USD","LIXT","LU0306807586.USD","LU0971552673.USD","LU1645745479.HKD","LU0321505868.SGD","LU0545562505.USD","LU1400636657.SGD","LU0058720904.USD","LU1400636574.HKD","LU0211331839.USD"],"gpt_icon":0},{"id":"2592125771","title":"Lixte Biotechnology Holdings, Inc.盘中异动 早盘股价大涨5.92%报4.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592125771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592125771?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:49","pubTimestamp":1766155765,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日22时49分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价快速上涨5.92%。截至发稿，该股报4.15美元/股，成交量7834股，换手率0.12%，振幅6.17%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121922492597a07f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121922492597a07f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXT"],"gpt_icon":0},{"id":"2592915323","title":"Lixte Biotechnology Holdings, Inc.股价重挫11.36% 市值跌84.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592915323?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:30","pubTimestamp":1766068209,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时30分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价快速跳水11.36%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822301097a075d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822301097a075d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"gpt_icon":0},{"id":"1165356795","title":"Lixte Biotechnology Holdings Inc. 宣布以市场定价进行430万美元的注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1165356795","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165356795?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:03","pubTimestamp":1766066618,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings Inc. 宣布以市场定价进行430万美元的注册直接发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"gpt_icon":0},{"id":"1113893113","title":"Lixte Biotechnology收购Liora Technologies的专有质子治疗平台用于癌症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1113893113","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113893113?lang=zh_cn&edition=full","pubTime":"2025-11-25 21:31","pubTimestamp":1764077471,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology收购Liora Technologies的专有质子治疗平台用于癌症治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIXTW","LIXT","BK4139"],"gpt_icon":0},{"id":"2580413916","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)盘中异动 快速下挫29.82%报0.100美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580413916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580413916?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:32","pubTimestamp":1761917526,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日21时32分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价急速下跌29.82%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体跌幅为0.28%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031213206a6d906cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031213206a6d906cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139","LIXTW"],"gpt_icon":0},{"id":"2579187021","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)盘中异动 早盘股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187021?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:32","pubTimestamp":1761744743,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日21时32分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价大幅拉升6.25%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体跌幅为0.27%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029213223a6d4f82a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029213223a6d4f82a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXT","LIXTW"],"gpt_icon":0},{"id":"2579472779","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价飙升16.38% 市值涨4382.29万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579472779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579472779?lang=zh_cn&edition=full","pubTime":"2025-10-28 21:31","pubTimestamp":1761658290,"startTime":"0","endTime":"0","summary":"北京时间2025年10月28日21时31分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价大幅拉升16.38%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为0.27%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028213130a479e69c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028213130a479e69c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139","LIXTW"],"gpt_icon":0},{"id":"1128862557","title":"Lixte Biotechnology Holdings 突出 2025 年第四季度优先事项，涵盖主导候选药物 Lb-100 的持续推进、战略性肿瘤业务发展及收购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1128862557","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128862557?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:01","pubTimestamp":1760616112,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings 突出 2025 年第四季度优先事项，涵盖主导候选药物 Lb-100 的持续推进、战略性肿瘤业务发展及收购计划","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIXT","BK4139","LIXTW"],"gpt_icon":0},{"id":"2575759832","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575759832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575759832?lang=zh_cn&edition=full","pubTime":"2025-10-15 23:07","pubTimestamp":1760540870,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日23时07分，Lixte Biotechnology Holdings, Inc.股票出现异动，股价急速下挫5.17%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101523075094cb1932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101523075094cb1932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"gpt_icon":0},{"id":"2572535356","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)盘中异动 快速上涨9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572535356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572535356?lang=zh_cn&edition=full","pubTime":"2025-10-04 03:21","pubTimestamp":1759519319,"startTime":"0","endTime":"0","summary":"北京时间2025年10月04日03时21分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现波动，股价急速拉升9.29%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为0.21%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251004032200a6ac5bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251004032200a6ac5bd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXTW","LIXT"],"gpt_icon":0},{"id":"2569718486","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价重挫18.37% 市值跌803.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569718486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569718486?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:29","pubTimestamp":1758551367,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日22时29分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现波动，股价大幅下跌18.37%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为0.72%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092222292797a29c0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092222292797a29c0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXTW","LIXT","BK4139"],"gpt_icon":0},{"id":"2568943194","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大涨5.26%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568943194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568943194?lang=zh_cn&edition=full","pubTime":"2025-09-16 21:38","pubTimestamp":1758029892,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日21时38分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价大幅上涨5.26%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。公司认为，蛋白磷酸酶抑制剂对多种癌症具有治疗潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091621381297963abb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091621381297963abb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"gpt_icon":0},{"id":"2562777461","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)盘中异动 早盘股价大跌6.83%报0.180美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562777461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562777461?lang=zh_cn&edition=full","pubTime":"2025-08-27 21:55","pubTimestamp":1756302936,"startTime":"0","endTime":"0","summary":"北京时间2025年08月27日21时55分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价急速下跌6.83%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为0.06%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082721553695009bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082721553695009bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","BK4139"],"gpt_icon":0},{"id":"2562068032","title":"Lixte Biotechnology Holdings, Inc.盘中异动 股价大跌5.57%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562068032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562068032?lang=zh_cn&edition=full","pubTime":"2025-08-26 03:29","pubTimestamp":1756150167,"startTime":"0","endTime":"0","summary":"北京时间2025年08月26日03时29分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价快速下挫5.57%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Tharimmune, Inc.涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为3954.86%、1657.30%、1158.98%，振幅较大的相关个股有Tharimmune, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Hcw Biologics Inc.，振幅分别为90.68%、77.88%、70.99%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一类名为蛋白磷酸酶2A抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508260329279760718e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508260329279760718e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXT"],"gpt_icon":0},{"id":"2517290299","title":"Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)股价重挫59.76% 市值跌1999.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517290299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517290299?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:55","pubTimestamp":1741208101,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时55分，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票出现异动，股价大幅下挫59.76%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 股票所在的生物技术行业中，整体涨幅为1.97%。Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045502a261318b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045502a261318b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXTW","LIXT","BK4139"],"gpt_icon":0},{"id":"2516581652","title":"Lixte Biotechnology Holdings, Inc.盘中异动 下午盘快速跳水5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516581652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516581652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:36","pubTimestamp":1741026978,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时36分，Lixte Biotechnology Holdings, Inc.股票出现波动，股价急速下跌5.38%。Lixte Biotechnology Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4402.35%、195.56%、179.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Lixte Biotechnology Holdings, Inc.公司简介：Lixte Biotechnology Holdings Inc 是一家生物制药公司，致力于通过开发一种名为蛋白磷酸酶 2A 抑制剂的药物来改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023618989a46cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023618989a46cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIXT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lixte.com","stockEarnings":[{"period":"1week","weight":-0.0166},{"period":"1month","weight":-0.1081},{"period":"3month","weight":-0.2945},{"period":"6month","weight":-0.2414},{"period":"1year","weight":1.25},{"period":"ytd","weight":-0.2443}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lixte Biotechnology Holdings, Inc.于2005年5月24日以特拉华州公司的名义注册成立，名称为SRKP 7，Inc。2006年12月7日，公司更名为Lixte Biotechnology Holdings，Inc.。该公司是一家药物发现公司。使用生物标记技术来识别与严重常见疾病相关的酶靶标，然后设计新颖的化合物来攻击那些靶标。该公司的产品线主要专注于蛋白质磷酸酶抑制剂，可单独使用或与细胞毒性剂和X射线和免疫检查点阻滞剂组合使用，涵盖临床前和临床开发各个阶段的两大类化合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.153774},{"month":2,"riseRate":0.625,"avgChangeRate":0.067639},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.047366},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.105051},{"month":5,"riseRate":0.375,"avgChangeRate":-0.005082},{"month":6,"riseRate":0.5,"avgChangeRate":0.031165},{"month":7,"riseRate":0.625,"avgChangeRate":0.400968},{"month":8,"riseRate":0.5,"avgChangeRate":0.097631},{"month":9,"riseRate":0.375,"avgChangeRate":0.00973},{"month":10,"riseRate":0.375,"avgChangeRate":-0.019298},{"month":11,"riseRate":0.375,"avgChangeRate":-0.035386},{"month":12,"riseRate":0.25,"avgChangeRate":-0.145393}],"exchange":"NASDAQ","name":"Lixte Biotechnology Holdings Inc.","nameEN":"Lixte Biotechnology Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lixte Biotechnology Holdings Inc.(LIXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lixte Biotechnology Holdings Inc.(LIXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lixte Biotechnology Holdings Inc.,LIXT,Lixte Biotechnology Holdings Inc.股票,Lixte Biotechnology Holdings Inc.股票老虎,Lixte Biotechnology Holdings Inc.股票老虎国际,Lixte Biotechnology Holdings Inc.行情,Lixte Biotechnology Holdings Inc.股票行情,Lixte Biotechnology Holdings Inc.股价,Lixte Biotechnology Holdings Inc.股市,Lixte Biotechnology Holdings Inc.股票价格,Lixte Biotechnology Holdings Inc.股票交易,Lixte Biotechnology Holdings Inc.股票购买,Lixte Biotechnology Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lixte Biotechnology Holdings Inc.(LIXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lixte Biotechnology Holdings Inc.(LIXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}